What do the best and worst performing funds tell us about the market?
2 mins. to read
Nick Sudbury looks at the best and worst performing funds and investment trusts over the last 12 months.
Nick Sudbury
The fund that has outperformed in 14 of the last 15 years
2 mins. to read
Neil Hermon’s excellent long-term track record in charge of the Henderson Smaller Companies investment trust has transformed the fund into a core holding for anyone who wants exposure to this part of the market.
The value funds that could benefit from higher interest rates
2 mins. to read
Historically, a rising interest rate environment has tended to favour value, so now could be the perfect time to increase your exposure to UK value funds.
The value fund that has outperformed
2 mins. to read
Investec Global Special Situations is a global value fund that has produced some excellent returns despite the fact that value stocks have tended to lag behind growth.
What will the end of QE mean for European equity funds?
3 mins. to read
Nick Sudbury looks at the performance of European equity funds during the period of QE and assess what is going to happen now they are starting to reverse the process.
Healthcare and Biotech funds: A promising prognosis – MAGAZINE EXCLUSIVE MAGAZINE EXCLUSIVE
9 mins. to read
There are only a handful of investment trusts and funds that concentrate on healthcare and biotech. Nick Sudbury looks at some of the best options.
Buying opportunity for Vietnam Enterprise Investments
2 mins. to read
Numis have just added the Vietnam Enterprise Investments trust as a trading buy following a recent correction, as they believe the outlook for Vietnam is really positive.
The new fund that earns royalties from hit songs
2 mins. to read
A new investment company has just floated on the LSE and is the first to provide exposure to music royalty and related income from a portfolio of different songs. The Hipgnosis Songs Fund is targeting annual NAV returns of 10% with a 5% prospective yield.
Are things about to get better for Woodford Patient Capital?
2 mins. to read
Woodford Patient Capital Trust has had a tough time of late but one of its unlisted holdings has had a successful IPO on the NASDAQ stock exchange prompting a major uplift in NAV.
The winners and losers since the EU referendum
2 mins. to read
Nick Sudbury looks at the performance of the UK funds and trusts sector since the Brexit vote.